Instent CTO—What Is the Best Treatment Strategy? Mark SahyouniGeorge A. Stouffer Editorial 25 January 2024 Pages: 393 - 394
Poking and Prodding So They Take Their Pills Revati ReddyJames C. Blankenship Editorial 11 July 2023 Pages: 395 - 396
When Less is More: Drug-Coated Balloons Threaten a Paradigm Revolution Bilal AlqamJames C Blankenship Editorial 19 December 2023 Pages: 397 - 399
Open Issues in the Management of Otcagerian Patients with Atrial Fibrillation and Chronic Kidney Disease: Are we Ready for Left Atrial Appendage Occlusion (LAAO) as First-Line Therapy for Thromboembolic Risk Prevention? Francesco CondelloAngelica CersosimoPaolo Pagnotta Editorial 26 January 2024 Pages: 401 - 403
Impairment of Vascular Homeostasis in Acute Heart Failure: Enter the Monocyte? Saifei LiuIndy AJ LawrieJohn D. Horowitz Invited Editorial 23 March 2024 Pages: 405 - 409
Beyond Hepatoprotection—The Cardioprotective Effects of Bicyclol in Diabetes Arun SamiduraiRakesh C. Kukreja Invited Editorial 06 December 2023 Pages: 411 - 413
C/EBP Homologous Protein: A Potential Therapeutic Target for Atherosclerosis Treatment? Jinjiao ShanSanlong LiuJingguang Zhu Letter to the Editor 16 January 2023 Pages: 415 - 415
Possible Cardioprotective Effects of Lactate Infusion After Cardiac Arrest or Prolonged Myocardial Ischemia Takashi Koyama Letter to the Editor 14 November 2023 Pages: 417 - 418
IL-33 in Atherosclerosis: An Insufficiently Explored and Controversial Research Area Yanyan YeFangyuan ChangYingchun Xu Letter to the Editor 31 January 2024 Pages: 419 - 420
The Potential Cardiovascular Benefits of COVID-19 Vaccination: Lessons from Influenza and Emerging Evidence Chia Siang KowDinesh Sangarran RamachandramSyed Shahzad Hasan Letter to the Editor 08 July 2023 Pages: 421 - 422
MicroRNA-92a in Cardiovascular Disease: An Insufficiently Explored and Controversial Research Area Jin-Zhen CuiYue-Min YuanYan-Yu Lin Letter to the Editor 01 December 2023 Pages: 423 - 424
Promising Drug Fondaparinux for the Treatment of COVID-19: an In Silico Analysis of Low Molecular Weight Heparin, Direct Oral Anticoagulant, and Antiplatelet Drug Interactions with Host Protease Furin Tugba Ertan-BolelliKayhan BolelliF. Burcu Belen-Apak Original Article 19 November 2022 Pages: 425 - 432
Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial Kishal LukhnaHelison R. P. do CarmoDerek M. Yellon Original Article Open access 29 November 2022 Pages: 433 - 445
Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study Roy O. MathewMandeep S. SidhuMichael E. Farkouh Original Article 29 November 2022 Pages: 447 - 457
Comparative Muscle Tolerability of Different Types and Intensities of Statins: A Network Meta-Analysis of Double-Blind Randomized Controlled Trials Qingtao HouYuqin ChenCaishuang Pang Original Article 30 November 2022 Pages: 459 - 469
Left Bundle Branch Area Pacing versus Biventricular Pacing for Cardiac Resynchronization Therapy on Morbidity and Mortality Yixiu LiangZilong XiaoJunbo Ge Original Article 02 December 2022 Pages: 471 - 481
Left Ventricular Thrombus Management After Acute Myocardial Infarction in Clinical Practice: Results from LEVITATION Survey and Narrative Review Luca A. F. Di OdoardoMatteo BiancoEnrico Cerrato Original Article 20 December 2022 Pages: 483 - 492
Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials Wolfgang KoenigLorena Garcia CondeFrederick J. Raal Original Article Open access 23 December 2022 Pages: 493 - 503
Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease Wei-Chieh LeeTing-Wei LiaoMien-Cheng Chen Original Article Open access 07 January 2023 Pages: 505 - 515
The Association of Proton Pump Inhibitors and QT Interval Prolongation in Critically Ill Patients Weiguo FanHualong LiuKui Hong Original Article 10 January 2023 Pages: 517 - 525
Mitogen-Activated Protein Kinases Mediate Adventitial Fibroblast Activation and Neointima Formation via GATA4/Cyclin D1 Axis Jing ChenJin-Qiu WeiXiao-Dong Li Original Article 18 January 2023 Pages: 527 - 538
Vaccine Targeting Alpha 1D-Adrenergic Receptor Improved Metabolic Syndrome in Mice Xin LiWenrui MaZihua Zhou Original Article Open access 19 January 2023 Pages: 539 - 554
Bicyclol Alleviates Streptozotocin-induced Diabetic Cardiomyopathy By Inhibiting Chronic Inflammation And Oxidative Stress Lingxi ZhangChenghong HuYing He Original Article 20 January 2023 Pages: 555 - 568
IL-33 Suppresses the Progression of Atherosclerosis via the ERK1/2-IRF1-VCAM-1 Pathway Zhang QianFeng ShaofangLiu Chao Original Article 14 November 2023 Pages: 569 - 580
PrevAleNce and Associated factors of inappropriaTe dosing of direct Oral anticoaguLants In pAtients with Atrial Fibrillation: the ANATOLIA-AF Study Umut KocabaşIsil Erginon behalf of the ANATOLIA-AF . study investigators Original Article 17 December 2022 Pages: 581 - 599
Correction to: Prevalence and Associated Factors of Inappropriate Dosing of Direct Oral Anticoagulants In Patients With Atrial Fibrillation: The ANATOLIA-AF Study Umut KocabaşIsil Erginon behalf of the ANATOLIA-A. F. study investigators Correction 19 January 2023 Pages: 601 - 603
The Cost of Breaking Even: a Perspective on the Net Clinical Impact of Adding Aspirin to Antithrombotic Therapies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Jeffrey TriskaFaris HaddadinHani Jneid Review Article 13 July 2022 Pages: 605 - 619
Influence of Genetic and Epigenetic Factors of P2Y12 Receptor on the Safety and Efficacy of Antiplatelet Drugs Dorota DanielakKornel PawlakMarta Karaźniewicz-Łada Review Article Open access 09 August 2022 Pages: 621 - 636
Direct Oral Anticoagulants: Navigating Through Clinical Challenges Maria IoannouElena LeonidouAngeliki Mouzarou Review Article 08 August 2023 Pages: 637 - 650
Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension Justin K. LuiRuchika A. SanganiElizabeth S. Klings Short Communication 06 January 2023 Pages: 651 - 656
Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis‑Related Pulmonary Hypertension Justin K. LuiRuchika A. SanganiElizabeth S. Klings Correction 20 January 2023 Pages: 657 - 657
